Similarly, it has previously been shown that shRNA-mediated silencing of ΔNTP63 expression in 5637 bladder cancer cells resulted in cell cycle arrest, a decreased proliferation rate and Cyclin D1 downregulation. The gene discussed is CCND1; the disease is urinary bladder carcinoma.